Journal IJCRT UGC-CARE, UGCCARE( ISSN: 2320-2882 ) | UGC Approved Journal | UGC Journal | UGC CARE Journal | UGC-CARE list, New UGC-CARE Reference List, UGC CARE Journals, International Peer Reviewed Journal and Refereed Journal, ugc approved journal, UGC CARE, UGC CARE list, UGC CARE list of Journal, UGCCARE, care journal list, UGC-CARE list, New UGC-CARE Reference List, New ugc care journal list, Research Journal, Research Journal Publication, Research Paper, Low cost research journal, Free of cost paper publication in Research Journal, High impact factor journal, Journal, Research paper journal, UGC CARE journal, UGC CARE Journals, ugc care list of journal, ugc approved list, ugc approved list of journal, Follow ugc approved journal, UGC CARE Journal, ugc approved list of journal, ugc care journal, UGC CARE list, UGC-CARE, care journal, UGC-CARE list, Journal publication, ISSN approved, Research journal, research paper, research paper publication, research journal publication, high impact factor, free publication, index journal, publish paper, publish Research paper, low cost publication, ugc approved journal, UGC CARE, ugc approved list of journal, ugc care journal, UGC CARE list, UGCCARE, care journal, UGC-CARE list, New UGC-CARE Reference List, UGC CARE Journals, ugc care list of journal, ugc care list 2020, ugc care approved journal, ugc care list 2020, new ugc approved journal in 2020, ugc care list 2021, ugc approved journal in 2021, Scopus, web of Science.
How start New Journal & software Book & Thesis Publications
Submit Your Paper
Login to Author Home
Communication Guidelines

WhatsApp Contact
Click Here

  Published Paper Details:

  Paper Title

STUDY OF INDIGENOUS COVID-19 VACCINE- ``COVAXIN``

  Authors

  Saurabh P. Bodake.,  Vipul M. Patil,  Sachinkumar V. Patil

  Keywords

Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), Pandemic, COVAXIN, Immunogenicity and Safety, Clinical Trials.

  Abstract


Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel human coronavirus, has spread across the world. SARS-CoV-2 belongs to b-genus of Sarbecovirus and is a close relative of SARS-CoV with approximately 80% sequence identity. In March 2020, the World Health Organization (WHO) proclaimed the SARS-CoV-2-caused disease coronavirus disease-19 (COVID-19), a pandemic. Therefore, it is imperative to develop effective prophylactic and therapeutic counter measures to prevent and treat COVID-19. Numerous vaccine candidates such as adenovirus-vectored, nucleic-acid-based, recombinant-protein based, and inactivated vaccines are at various stages of developmental phase at either preclinical or clinical trials. However, meeting the global need for billions of doses of COVID-19 vaccines will require collective effort to identify, evaluate, validate, and manufacture effective vaccines. This review article gives detailed information about the study of India’s first Indigenous COVID-19 vaccine “COVAXIN”. The main objective of this review is to get more information about its preclinical study, formulation, as well as its safety and efficacy in various phases of clinical trials.

  IJCRT's Publication Details

  Unique Identification Number - IJCRT2106627

  Paper ID - 209126

  Page Number(s) - f285-f300

  Pubished in - Volume 9 | Issue 6 | June 2021

  DOI (Digital Object Identifier) -   

  Publisher Name - IJCRT | www.ijcrt.org | ISSN : 2320-2882

  E-ISSN Number - 2320-2882

  Cite this article

  Saurabh P. Bodake.,  Vipul M. Patil,  Sachinkumar V. Patil,   "STUDY OF INDIGENOUS COVID-19 VACCINE- ``COVAXIN``", International Journal of Creative Research Thoughts (IJCRT), ISSN:2320-2882, Volume.9, Issue 6, pp.f285-f300, June 2021, Available at :http://www.ijcrt.org/papers/IJCRT2106627.pdf

  Share this article

  Article Preview

  Indexing Partners

indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
Call For Paper May 2024
Indexing Partner
ISSN and 7.97 Impact Factor Details


ISSN
ISSN
ISSN: 2320-2882
Impact Factor: 7.97 and ISSN APPROVED
Journal Starting Year (ESTD) : 2013
ISSN
ISSN and 7.97 Impact Factor Details


ISSN
ISSN
ISSN: 2320-2882
Impact Factor: 7.97 and ISSN APPROVED
Journal Starting Year (ESTD) : 2013
ISSN
DOI Details

Providing A Free digital object identifier by DOI.one How to get DOI?
For Reviewer /Referral (RMS) Earn 500 per paper
Our Social Link
Open Access
This material is Open Knowledge
This material is Open Data
This material is Open Content
Indexing Partner

Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 7.97 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer